胆固醇酯转移蛋白抑制与年龄相关性黄斑变性风险
该研究采用药物靶点孟德尔随机化和观察性遗传关联分析,在英国生物银行和新加坡眼病流行病学研究人群中评估遗传 proxy 的 CETP 抑制与 AMD 风险的关联。结果显示,在欧洲和东亚裔人群中,更强的遗传 proxy CETP 抑制与更高的 AMD 风险相关,提示潜在的视网膜安全性信号,需临床试验和纵向观察验证。
要点
- 遗传 proxy 的 CETP 抑制与欧洲裔晚期和早期 AMD 风险升高相关。
- 东亚裔中,遗传 proxy 的 CETP 抑制与渗出性 AMD、典型 nAMD 和 PCV 风险升高相关。
- SEED 研究中 HDL 加权 CETP 遗传评分与早期 AMD 患病呈 U 型关联。
核心结论
- 在欧洲和东亚裔人群中,更强的遗传 proxy CETP 抑制与更高的 AMD 风险相关。
- 这些发现提出潜在的视网膜安全性信号,需在临床试验和临床实践中的纵向观察研究中验证。
研究设计与样本
- 药物靶点孟德尔随机化与观察性遗传关联分析,纳入英国生物银行和新加坡眼病流行病学研究。
- 英国生物银行基线无 AMD 参与者 457,242 人,SEED 参与者 7,058 人。
- 药物靶点 MR 中,欧洲裔使用 CETP 蛋白定量性状基因座工具,东亚裔使用 HDL 加权 CETP 区域工具。
主要发现
- 欧洲裔中,遗传 proxy CETP 抑制增强与晚期 AMD 风险升高相关(OR 1.45;95% CI 1.25, 1.67)。
- 欧洲裔中,遗传 proxy CETP 抑制增强与早期 AMD 风险升高相关(OR 1.29;95% CI 1.19, 1.41)。
- 东亚裔中,遗传 proxy CETP 抑制增强与渗出性 AMD 风险升高相关(OR 3.14;95% CI 2.16, 4.57)。
- 东亚裔中,遗传 proxy CETP 抑制增强与典型 nAMD 风险升高相关(OR 2.84;95% CI 1.69, 4.79)。
- 东亚裔中,遗传 proxy CETP 抑制增强与 PCV 风险升高相关(OR 3.18;95% CI 2.05, 4.93)。
关键数值与推荐
- 英国生物银行中,CETP pQTL 评分每降低 1 SD(代表遗传 proxy CETP 抑制增强)与 incident AMD 风险升高相关(HR 1.03;95% CI 1.01, 1.06;P=0.008)。
- SEED 中,HDL 加权 CETP 遗传评分与 prevalent early AMD 呈 U 型关联。
- 与中间组相比,最高十分位组(代表遗传 proxy CETP 抑制增强)的 OR 为 1.74(95% CI 1.07, 2.72;P=0.019)。
- 与中间组相比,最低三分位组(代表抑制较弱)的 OR 为 1.50(95% CI 1.13, 1.99;P=0.005)。
临床怎么用
- 使用 CETP 抑制剂时需关注 AMD 风险,尤其在有 AMD 风险因素的患者中。
- 该遗传学证据提示需在临床实践中开展纵向观察研究验证视网膜安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Cholesteryl ester transfer protein (CETP) inhibitors have shown cardiovascular benefits, but genetically proxied CETP inhibition may increase age-related macular degeneration (AMD) risk. We evaluated this association in European- and East Asian-ancestry populations. DESIGN: Drug-target Mendelian randomization (MR) and observational genetic association analyses in the UK Biobank and the Singapore Epidemiology of Eye Diseases (SEED) study. PARTICIPANTS: 457,242 UK Biobank participants without AMD at baseline and 7,058 SEED participants. METHODS: In drug-target MR, CETP inhibition was instrumented using a CETP protein quantitative trait locus (pQTL) instrument in Europeans and a high-density lipoprotein (HDL)-weighted CETP-region instrument in East Asians. Outcomes included advanced and early AMD in Europeans and exudative AMD, typical neovascular AMD (nAMD), and polypoidal choroidal vasculopathy (PCV) in East Asians. In observational analyses, a CETP pQTL score was evaluated against incident AMD in the UK Biobank, and an HDL-weighted CETP genetic score against prevalent AMD in SEED. MAIN OUTCOME MEASURES: Risk of AMD RESULTS: In drug-target MR, greater genetically proxied CETP inhibition was associated with higher risks of advanced AMD (OR, 1.45; 95% CI, 1.25, 1.67) and early AMD (OR, 1.29; 95% CI, 1.19, 1.41) in Europeans, and exudative AMD (OR, 3.14; 95% CI, 2.16, 4.57), typical nAMD (OR, 2.84; 95% CI, 1.69, 4.79), and PCV (OR, 3.18; 95% CI, 2.05, 4.93) in East Asians (all P<0.001). In UK Biobank, each 1-SD decrease in the CETP pQTL score, representing greater genetically proxied CETP inhibition, was associated with higher incident AMD risk (HR,1.03; 95% CI, 1.01, 1.06; P=0.008). In SEED, the HDL-weighted CETP genetic score showed a U-shaped association with prevalent early AMD. Compared with the midrange group, higher odds were observed in the highest decile, representing greater genetically proxied CETP inhibition (OR, 1.74; 95% CI, 1.07, 2.72; P=0.019), and the lowest tertile, representing weaker inhibition (OR, 1.50; 95% CI, 1.13, 1.99; P=0.005). CONCLUSIONS: Greater genetically proxied CETP inhibition was associated with higher AMD risk across genetic analyses in European- and East Asian-ancestry populations. These findings raise a potential retinal safety signal requiring validation in clinical trials and longitudinal observational studies in clinical practice.
引用
- Xue CC, Li H, Wang S, et al. Cholesteryl Ester Transfer Protein Inhibition and Risk of Age-Related Macular Degeneration. Ophthalmology. 2026. PMID: 42810526. doi:10.1016/j.ophtha.2026.09.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。